Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: Factors related to tumour thickness

Acta Dermato-Venereologica

Volumn 86, Issue 1, 2006, Pages 50-56

  Nagore, Eduardo ^a,c   Oliver, Vicente ^b   Botella Estrada, Rafael ^a   Moreno Picot, Salvador ^a   Guillén, Carlos ^a   Fortea, José M ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c NONE   (Spain)

Author keywords

Breslow; Epidemiology; Melanoma; Public awareness campaigns; Thickness

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SPAIN; TUMOR VOLUME; AGE; BLEEDING; FOOT; HAND; LYMPH NODE METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; RETROSPECTIVE STUDY; SENSORY DYSFUNCTION; SEX DIFFERENCE; SKIN TUMOR; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FOOT; HAND; HEMORRHAGE; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SENSATION DISORDERS; SEX FACTORS; SKIN NEOPLASMS; SPAIN;

EID: 33744748905     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0004     Document Type: Article

References (30)

1. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004; 150: 179-185.
2. MacKie R, Hunter JA, Aitchison TC, Hole D, McLaren K, Rankin R, et al. Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet 1992; 339: 971-975.
3. Hersey P, Sillar RW, Howe CG, Burton RC, Darbar SV, Foster HM, et al. Factors related to the presentation of patients with thick primary melanomas. Med J Aust 1991; 154: 583-587.
4. Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000; 89: 1269-1278.
5. Thorn M, Pontén F, Bergström R, Sparen P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 1994; 86: 761-769.
6. Karjalainen S, Hakulinen T. Survival and prognostic factors of patients with skin melanoma. A regression-model analysis based on nationwide cancer registry data. Cancer 1988; 62: 2274-2280.
7. Blois MS, Sagebiel RW, Abarbanel RM, Caldwell TM, Tuttle MS. Malignant melanoma of the skin. I. The association of tumor depth and type, and patient sex, age, and site with survival. Cancer 1983; 52: 1330-1341.
8. Saxe N, Hoffman M, Krige JE, Sayed R, King HS, Hounsell K. Malignant melanoma in Cape Town, South Africa. Br J Dermatol 1998; 138: 998-1002.
9. Carli P, Borgognoni L, Biggeri A, Carli S, Reali UM, Giannotti B. Incidence of cutaneous melanoma in the centre of Italy: anatomic site distribution, histologic types and thickness of tumour invasion in a registry-based study. Melanoma Res 1994; 4: 385-390.
10. Stanganelli I, Raccagni AA, Baldassari L, Calista D, Serafini M, Bucchi L. Analysis of Breslow tumor thickness distribution of skin melanoma in the Italian region of Romagna, 1986-1991. Tumori 1994; 80: 416-421.
11. Ocana-Riola R, Martinez-Garcia C, Serrano S, Buendia-Eisman A, Ruiz-Baena C, Canela-Soler J. Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985-1992. Eur J Epidemiol 2001; 17: 169-174.
12. Castel T, Baradad M, Castro J, Mascaro JM, Garcia-Valdecasas JC, Grande L, et al. [Primary malignant melanoma of the skin. Retrospective study of 375 cases. Clinical aspects and histology.] Med Clin (Barc) 1990; 94: 246-249. (In Spanish)
13. Montella M, Crispo A, Grimaldi M, De Marco MR, Ascierto PA, Parasole R, et al. An assessment of factors related to tumor thickness and delay in diagnosis of melanoma in southern Italy. Prev Med 2002; 35: 271-277.
14. Balzi D, Carli P, Giannotti B, Buiatti E. Skin melanoma in Italy: a population-based study on survival and prognostic factors. Eur J Cancer 1998; 34: 699-704.
15. Bucchi L, Serafini M, Lanzanova G. Breslow thickness of cutaneous malignant melanoma in Ravenna (northern Italy) 1981-1990. Tumori 1992; 78: 94-97.
16. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-908.
17. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-3634.
18. Melia J, Cooper EJ, Frost T, Graham-Brown R, Hunter J, Marsden A, et al. Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma. Br J Dermatol 1995; 132: 414-421.
19. Osborne JE, Hutchinson PE. Clinical correlates of Breslow thickness of malignant melanoma. Br J Dermatol 2001; 144: 476-483.
20. Brochez L, Verhaeghe E, Bleyen L, Naeyaert JM. Time delays and related factors in the diagnosis of cutaneous melanoma. Eur J Cancer 2001; 37: 843-848.
21. Oliveria SA, Christos PJ, Halpern AC, Fine JA, Barnhill RL, Berwick M. Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma. J Clin Epidemiol 1999; 52: 1111-1116.
22. Herd RM, Cooper EJ, Hunter JA, McLaren K, Chetty U, Watson AC, et al. Cutaneous malignant melanoma. Publicity, screening clinics and survival - the Edinburgh experience 1982-90. Br J Dermatol 1995; 132: 563-570.
23. Conde JM, Contreras F, Moreno A, Patron M, Rodriguez JL, Salvatella N, et al. [Malignant melanoma in Spain. Cooperative clinicopathologic study of 513 cases.] Med Clin (Barc) 1987; 88: 525-528. (In Spanish)
24. Gardeazabal J, Regalado J, Fernandez F, Pijoan J, Gabilondo F, Diaz J. Estudio comparativo de los pacientes con melanoma en el Hospital de Cruces entre las décadas 1977-1986 y 1987-1996. Med Cut Iber Lat Am 2000; 28: 236-240.
25. Magnus K. Prognosis in malignant melanoma of the skin. Significance of stage of disease, anatomical site, sex, age and period of diagnosis. Cancer 1977; 40: 389-397.
26. Masback A, Olsson H, Westerdahl J, Ingvar C, Jonsson N. Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review. Melanoma Res 2001; 11: 435-445.
27. Kemeny MM, Busch E, Stewart AK, Menck HR. Superior survival of young women with malignant melanoma. Am J Surg 1998; 175: 437-44; discussion 444-445.
28. Bell M, Beyl CM, Schopf RE, Schramm P. Light exposure of the lower leg as a pathogenetic factor in the occurrence of malignant melanoma. Dermatology 1992; 185: 257-261.
29. Richard MA, Grob JJ, Avril MF, Delaunay M, Thirion X, Wolkenstein P, et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol 1999; 135: 269-274.
30. Schmid-Wendtner MH, Baumert J, Stange J, Volkenandt M. Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients. Melanoma Res 2002; 12: 389-394.